• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Karyopharm - oncology





Ricky pussies out of presenting at SVB Leerink and the stock pops. That tells you pretty much all you need to know about what a pinhead train wreck the street thinks he is. Never a good sign when the best way a CEO can add value is to just shut his pie hole. Keep running off at the mouth and loving the sound of your own voice, Rickster. You won’t hear them laughing at you behind your back that way.
 
























































52 week low…maybe bringing in a first time CEO and a first time head of commercial, from the same big biotech wasn’t such a great idea after all…if we were selling a mass market supportive care therapy maybe…but these two people WERE NOT part of the original Onyx launch of Kyprolis…both barely brushed up against it…they greatly embellished their experiences in MM and with Kyprolis…
 




52 week low…maybe bringing in a first time CEO and a first time head of commercial, from the same big biotech wasn’t such a great idea after all…if we were selling a mass market supportive care therapy maybe…but these two people WERE NOT part of the original Onyx launch of Kyprolis…both barely brushed up against it…they greatly embellished their experiences in MM and with Kyprolis…

Ricky is a consummate bullshit artist. Always has been. He usually manages to stay six months ahead of the termination letters, though, and land somewhere else to repeat the process.
 








52 week low…maybe bringing in a first time CEO and a first time head of commercial, from the same big biotech wasn’t such a great idea after all…if we were selling a mass market supportive care therapy maybe…but these two people WERE NOT part of the original Onyx launch of Kyprolis…both barely brushed up against it…they greatly embellished their experiences in MM and with Kyprolis…

I think you meant to to say the stock hit an all-time low today. Ricky doesn’t mess around.
 




I think you meant to to say the stock hit an all-time low today. Ricky doesn’t mess around.


Good point! How does anyone leave their house and go into the field for this failure of a company? It is literary dead in the water, stock is worthless, product sucks, IC sucks, and sorry but 100 recognition points isn't motivating anyone. What's sad is they'll have you think that a $200K base salary is a lot of money, meanwhile SC and RP are making seven figures easy...all for driving the company into the ground.

Good thing is there are companies starting to buildout again...another wave of resignations on its way.